MRK
Merck & Co., Inc.
NYSE · USD · Stock
$149.52
+0.24 (+0.16%)
past month
Closed- Market cap
- $368.89B
- P/E
- 151.03
- Yield
- 2.27%
- Volume
- 12.3M
- 52 weeks
- $82.01 – $157
About
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands.
Merck & Co., Inc. (MRK) is a healthcare company listed on NYSE, traded in USD. Over the past year it moved between $82.01 and $156.92, and it pays a dividend every quarter.
- Healthcare
- Drug Manufacturers - General
- Rahway, United States
- 73K employees
- Led by Robert M. Davis J.D.
Financials
Revenue, last 12 months
$67.38B+4.70%
Earnings
Beat the estimate
4 of 4 quarters
Q4 2025
+1.47%
Q1 2026
+13.15%
Q2 2026
+49.43%
Q3 2026
+19.30%
Earnings per share, last 12 months $0.9900
Analysts
26 analysts say
Buy
12-month target$159.83+6.90%
Dividends
Yield · per share, yearly
2.27%$3.40
Split 1,048-for-1,000 on Jun 3, 2021
Ownership
- Institutions
- 82.88%
- Insiders
- 0.06%
Latest insider trade Aug 13, 2026, GUINDO CHIRFI
Prices from Yahoo Finance, may be delayed
